Lorenza Burzi

11PUBLICATIONS
25CO-AUTHORS
Proteins and peptidesBasic pharmacologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacology and pharmaceutical sciences not elsewhere classifiedRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 18, 2026
Selective IL-23 Inhibition in Conventional Treatment-Refractory Pyoderma Gangrenosum: A Multicenter, Retrospective Study.

|Jan 29, 2024
Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years.

Luca Mastorino, Paolo Dapavo, Lorenza Burzi

|Dec 26, 2023
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years.

L Mastorino, P Dapavo, L Burzi

|Sep 29, 2022
Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real-life experience and therapeutic response to other biological drugs.

Lorenza Burzi, Federica Repetto, Simone Ribero

|Sep 05, 2022
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness?

Gabriele Roccuzzo, Giulia Rozzo, Lorenza Burzi

Pageof 2

Frequent Collaborators

7 joint publications

Simone Ribero

5 joint publications

Federica Repetto

3 joint publications

Pietro Quaglino

2 joint publications

Michele Parietti